Marginal zone lymphoma causing accelerated progression of chronic kidney disease

por Samarasinghe, Amali, Wong, Daniel, Cull, Gavin, Chakera, Aron
Publicado 2019

Hydroa Vacciniforme-Like Lymphoproliferative Disorder in an Adult Patient With Chronic Lymphocytic Leukemia

por Chee, Ashlyn, Wood, Benjamin, Sadler, Genevieve, Cull, Gavin
Publicado 2020

Zanubrutinib, Alone and in Combination With Tislelizumab, for the Treatment of Richter Transformation of Chronic Lymphocytic Leukemia

por Tam, Constantine, Munoz, Javier, Cull, Gavin, Opat, Stephen, Allewelt, Heather, Zhang, Xiaoping, Stern, Jennifer C., Hilger, James, By, Kunthel, Cohen, Aileen, Tedeschi, Alessandra
Publicado 2023

PB1926: EFFICACY AND SAFETY OF ONCE DAILY (QD) VS TWICE DAILY (BID) ZANUBRUTINIB FOR PATIENTS WITH VARIOUS B-CELL MALIGNANCIES: A COMPARATIVE SUMMARY OF CLINICAL DATA AND EXPOSURE-...

por Tam, Constantine, Shadman, Mazyar, Sharman, Jeff, Cull, Gavin, Phillips, Tycel, Trotman, Judith, Cohen, Aileen, Allewelt, Heather, Crescenzo, Rocco, Delarue, Richard, Zhang, Heather, Tariq, Bilal, Sahasranaman, Sri, Ou, Ying C, Flinn, Ian W
Publicado 2023

Zanubrutinib for treatment‐naïve and relapsed/refractory chronic lymphocytic leukaemia: long‐term follow‐up of the phase I/II AU‐003 study

por Cull, Gavin, Burger, Jan A., Opat, Stephen, Gottlieb, David, Verner, Emma, Trotman, Judith, Marlton, Paula, Munoz, Javier, Johnston, Patrick, Simpson, David, Stern, Jennifer C., Prathikanti, Radha, Wu, Kenneth, Novotny, William, Huang, Jane, Tam, Constantine S.
Publicado 2021

An international multicenter retrospective analysis of patients with extranodal marginal zone lymphoma and histologically confirmed central nervous system and dural involvement

por Sunderland, Andrew J., Steiner, Raphael E., Al Zahrani, Musa, Pinnix, Chelsea C., Dabaja, Bouthaina Shbib, Gunther, Jillian R., Nastoupil, Loretta J., Jerkeman, Mats, Joske, David, Cull, Gavin, El‐Galaly, Tarec, Villa, Diego, Cheah, Chan Yoon
Publicado 2019

Extent of radiological response does not reflect survival in primary central nervous system lymphoma

por van der Meulen, Matthijs, Postma, Alida A, Smits, Marion, Bakunina, Katerina, Minnema, Monique C, Seute, Tatjana, Cull, Gavin, Enting, Roelien H, van der Poel, Marjolein, Stevens, Wendy B C, Brandsma, Dieta, Beeker, Aart, Doorduijn, Jeanette K, Issa, Samar, van den Bent, Martin J, Bromberg, Jacoline E C
Publicado 2021

Pooled safety analysis of zanubrutinib monotherapy in patients with B-cell malignancies

por Tam, Constantine S., Dimopoulos, Meletios, Garcia-Sanz, Ramon, Trotman, Judith, Opat, Stephen, Roberts, Andrew W., Owen, Roger, Song, Yuqin, Xu, Wei, Zhu, Jun, Li, Jianyong, Qiu, Lugui, D’Sa, Shirley, Jurczak, Wojciech, Cull, Gavin, Marlton, Paula, Gottlieb, David, Munoz, Javier, Phillips, Tycel, Du, Chenmu, Ji, Meng, Zhou, Lei, Guo, Haiyi, Zhu, Hongjie, Chan, Wai Y., Cohen, Aileen, Novotny, William, Huang, Jane, Tedeschi, Alessandra
Publicado 2022

Improvement in Parameters of Hematologic and Immunologic Function and Patient Well-being in the Phase III RESONATE Study of Ibrutinib Versus Ofatumumab in Patients With Previously...

por Barrientos, Jacqueline C., O’Brien, Susan, Brown, Jennifer R., Kay, Neil E., Reddy, Nishitha M., Coutre, Steven, Tam, Constantine, Mulligan, Stephen, Jaeger, Ulrich, Devereux, Stephen, Pocock, Christopher, Robak, Tadeusz, Schuster, Stephen J., Schuh, Anna, Gill, Devinder, Bloor, Adrian, Dearden, Claire, Moreno, Carol, Cull, Gavin, Hamblin, Mike, Jones, Jeffrey A., Eckert, Karl, Solman, Isabelle G., Suzuki, Samuel, Hsu, Emily, James, Danelle F., Byrd, John C., Hillmen, Peter
Publicado 2018